A medical study published on Monday finds that the Pfizer-BioNTech COVID-19 vaccine shows diminished efficacy after only six months, dropping to below 50 percent effectiveness after the second dose. Specifically, the Pfizer-funded study found that their own vaccine was 88 percent effective in the first month after full vaccination but dropped to 47 percent effective at about six months.
The Pfizer vaccine was shown to be greatly effective against the Delta variant – at over 90 percent – but in that study, the efficacy dropped to 53 percent effectiveness after only four months.
The researchers determined that weakening immunity was an effect of elapsed time since dosage, rather than the inherent strength and communicability of the Delta variant.
“Our results provide support for high effectiveness of [Pfizer-BioNTech COVID-19 vaccine] against hospital admissions up until around 6 months after being fully vaccinated, even in the face of widespread dissemination of the delta variant,” the researchers wrote. “Reduction in vaccine effectiveness against SARS-CoV-2 infections over time is probably primarily due to waning immunity with time rather than the delta variant escaping vaccine protection.”
Protection against severe symptoms requiring hospitalization held steady at 93 percent up to six months after administration of the second dose.
Overall, individuals fully vaccinated with the Pfizer-BioNTech vaccine had 73 percent effective protection against COVID-19 infection and a 90 percent effective protection against COVID-19 related hospitalization.
The study involved 3.4 million people ages 12 and up in the southern California area and took place between December of 2020 and August of 2021.
“Our results reiterate in a real-world US setting that vaccination with [the Pfizer-BioNTech COVID-19 vaccine] remains an essential tool for preventing COVID-19, especially COVID-19-associated hospital admissions, caused by all current variants of concern,” they wrote.
The study found that maximum efficacy reached 96.2 percent within two months after the second dose. The vaccine’s effectiveness declines thereafter at a rate of about six percent each month. The report comes on the heels of the Food and Drug Administration’s approval of a booster dose for elderly people and those with co-morbidities.
“We believe boosters have an important role to play in addressing the continued threat of this disease, alongside efforts to increase global access and uptake among the unvaccinated,” Pfizer CEO Albert Bourla said at the time.
Trouble may be brewing over at Pfizer and might soon be coming to other pharmaceutical companies which have manufactured their own versions of the COVID-19 vaccine.
Project Veritas released another undercover video in early October as part of their series that seeks to shed light upon alleged unscrupulous practices vis-a-vis Pfizer and its vaccine.
Scientists at the company revealed on the video that they are instructed to essentially ignore natural immunity in favor of pushing the vaccine, even though natural immunity has arguably longer-lasting efficacy.
Nick Karl, who is a biochemist at Pfizer involved in the development of their vaccine, stated, “When somebody is naturally immune — like they got COVID — they probably have more antibodies against the virus… When you actually get the virus, you’re going to start producing antibodies against multiple pieces of the virus… So, your antibodies are probably better at that point than the [COVID] vaccination.”
Pfizer Senior Associate Scientist Chris Croce noted, “You’re protected for longer” if you have natural antibodies working for you compared to the COVID vaccine. “I work for an evil corporation … Our organization is run on COVID money.”
“No one has the right to ask you if you’ve been vaccinated. It’s an invasion of privacy. I don’t agree with it. You have multiple companies that were basically given a crap ton of money to produce vaccines, and they’re pushing them,” he said.
Rahul Khandke, another Pfizer scientist, commented, “We’re bred and taught to be like ‘vaccine is safer than actually getting COVID.’ And that’s like, honestly… We have to do so many seminars on this. Like, you have no idea. We have to sit there for hours and hours and listen to, like, ‘You cannot talk about this. It’s not in public.’”
DONATE TO BIZPAC REVIEW
Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!
- Ukraine lawmaker pleased with Dem performance, says early results from midterms ‘very good’ for us - November 9, 2022
- Casey Anthony sits for first TV interview since being acquitted for murdering her 2-yr-old daughter - November 9, 2022
- Part-time Uber driver in FL rides anti-gun platform to become first Gen Z ‘progressive’ in Congress - November 9, 2022
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.